Navigation Links
The secret sex life of the penicillin-producing fungus could make it more productive
Date:1/14/2013

New and more effective strains of the fungus used to produce penicillin could be developed after a team of international scientists unearthed the secret sex life of Sir Alexander Fleming's fungus Penicillium chrysogenum (P. chrysogenum).

The scientists from The University of Nottingham, Ruhr-University Bochum, The University of Gttingen, and Sandoz GmbH have announced a major breakthrough in our understanding of the sex life of the fungus P. chrysogenum. Their research looks sets to lead to the introduction of new and more effective strains of the world's first antibiotic agent and has been published online in the leading academic journal Proceedings of the National Academy of Sciences USA (PNAS).

Penicillium chrysogenum is a filamentous fungus of major medical and historical importance. It is the original and present-day industrial source of the antibiotic penicillin. For over 100 years the fungus has been thought to be asexual, but the researchers have discovered a method to entice the fungus into sexual reproduction. They've demonstrated that sexual crosses can be used to develop new strains with improved industrial characteristics.

Dr Paul Dyer, an expert in the sexual development and genetics of filamentous fungi in the School of Biology at Nottingham, said: "We now have a valuable tool for creating new strains of P. chrysogenum with increased penicillin production. This will make it cheaper to produce penicillin, as using more efficient strains will lower production costs. In the future, it is hoped our method can be applied to other fungi that produce antibiotics."

Our method might also be used to help discover hidden sexual cycles in other economically important fungi that are assumed to be exclusively asexual."

The development of penicillin

Penicillium chrysogenum first came to attention in 1928 when Sir Alexander Fleming made the fortuitous discovery that a Penicillium mold, which had contaminated a bacterial culture, was able to inhibit the growth of nearby bacteria by releasing penicillin into its surroundings. Over 10 years later two scientists, Ernst Chain and Howard Florey, were the first to grow the fungus in large quantities to generate enough penicillin to treat patients. These events heralded the start of the antibiotic era, which has been one of the most important advances in medicine. Fleming, Chain, and Florey later shared the Nobel Prize in physiology/medicine. Since then it has only been possible to develop strains of P. chrysogenum with elevated production of penicillin by conventional mutagenesis.

The researchers found that sexual reproduction could be induced in P. chrysogenum when strains were mated in the dark on oatmeal with a vitamin supplement. They demonstrated that the sexual cycle could be used for strain development purposes by producing offspring with new combinations of important biotechnological properties for penicillin production, such as the removal of chrysogenin, a contaminating substance produced by the fungus. Furthermore, the team discovered that mating-type genes, which control sex in fungi, have additional roles regulating other developmental processes of biotechnological relevance.

Inducing sex in celibate fungi

Fungi are used to produce many important pharmaceutical products including statins and antibiotics, and most species involved have long been considered to be asexual. But the present findings suggest that sexual reproduction could be triggered in other supposedly asexual fungi if the mating-type genes and correct growth conditions can be identified.


'/>"/>
Contact: Lindsay Brooke
lindsay.brooke@nottingham.ac.uk
44-011-595-15751
University of Nottingham
Source:Eurekalert

Related biology news :

1. The secrets of a tadpoles tail and the implications for human healing
2. Host cholesterol secretion likely to influence gut microbiota
3. Secrets of gentle touch revealed
4. Biologists unlocking the secrets of plant defenses, 1 piece at a time
5. Fitness for toad sperm: The secret is to mate frequently
6. Pond skating insects reveal water-walking secrets
7. Biophysicists unravel secrets of genetic switch
8. Ancient genome reveals its secrets
9. New model gives hands-on help for learning the secrets of molecules
10. Decoding the secrets of balance
11. Hidden secrets in the worlds most northerly rainforests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... ... March 27, 2017 , ... IsoPlexis ... against cancer, autoimmune disease and more through a single-cell precision engineering platform, today ... analysis platform developed in the laboratory of Dr. James Heath at the ...
(Date:3/27/2017)... , March 27, 2017  Perthera,s Chief Bioinformatics ... Center, Subha Madhavan , Ph.D., will be speaking ... Summits Panels. On Monday, March 27, 2017, she will ... Data More Usable for Research and Care" (from 10:30 ... 28, 2017, she will be a participant in the ...
(Date:3/27/2017)... , March 27, 2017 DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... coverage option for U.S. consumers who want to have ... DarioHealth has signed strategic alliance agreements with partners across ... coverage benefits, and if approved, will supply and bill ...
(Date:3/24/2017)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), ... , today announced that its board of directors has amended its ... from March 27, 2017 to March 27, 2018. The amendment was not ... Biotech Ltd. ... Sinovac Biotech Ltd. is a China -based ...
Breaking Biology Technology: